⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15516303 | 0.78 | LMNA (0.45) | — | |
| SCHEMBL7211340 | 0.78 | LMNA (0.45) | — | |
| SCHEMBL28006477 | 0.74 | — | — | |
| SCHEMBL1617422 | 0.74 | — | — | |
| SCHEMBL9252715 | 0.74 | — | — | |
| SCHEMBL28046675 | 0.72 | LMNA (0.41) | — | |
| SCHEMBL27352153 | 0.72 | LMNA (0.46) | — | |
| SCHEMBL27943985 | 0.70 | BAZ2B (0.50) | — | |
| SCHEMBL7437060 | 0.70 | ADORA3 (0.50) | — | |
| SCHEMBL22327277 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0007470-B1 | CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-12 | — | — | EP | claimed |
| US-4268509-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-19 | — | — | US | claimed |
| US-4267176-A | Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-12 | — | — | US | claimed |
| EP-0007470-A2 | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-06 | — | — | EP | claimed |
| EP-3104707-B1 | TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS | ALBERT EINSTEIN COLLEGE MEDICINE INC (US) | 2020-07-15 | — | — | EP | disclosed |
| US-10294233-B2 | Treatment of H. pylori infections using MTAN inhibitors | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2019-05-21 | — | — | US | disclosed |
| US-20190016730-A1 | TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2019-01-17 | — | — | US | disclosed |
| EP-3104707-A1 | TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS | Albert Einstein College of Medicine, Inc. (US) | 2016-12-21 | — | — | EP | disclosed |
| WO-2015123101-A1 | TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2015-08-20 | — | — | WO | disclosed |
| CN-1284961-A | Erythromycin derivatives | HOKURIKU PHARMACEUTICAL (JP) | 2001-02-21 | — | — | CN | disclosed |
| EP-1044985-A1 | ERYTHROMYCIN DERIVATIVES | HOKURIKU SEIYAKU CO., LTD. (JP) | 2000-10-18 | — | — | EP | disclosed |
| US-4585872-A | CEPHALOSPORIN ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-04-29 | — | — | US | disclosed |
| EP-0036673-B1 | NEW THIADIAZOL COMPOUNDS AND PROCESSES FOR THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-11 | — | — | EP | disclosed |
| US-4447429-A | ANTIBIOTICS, BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-05-08 | — | — | US | disclosed |
| EP-0007470-B1 | CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-12 | — | — | EP | disclosed |
| EP-0036673-A1 | New thiadiazol compounds and processes for their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-30 | — | — | EP | disclosed |
| US-4268509-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-19 | — | — | US | disclosed |
| US-4206211-A | BACTERICIDES | FARMITALIA CARLO ERBA S.P.A. (IT) | 1980-06-03 | — | — | US | disclosed |
| EP-0007470-A2 | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-06 | — | — | EP | disclosed |